On Wednesday, Shares of Procter & Gamble Co (NYSE:PG), lost -0.01% to $70.89.
Cleveland Clinic is collaborating with Cleveland HeartLab and Procter & Gamble (PG) to develop and commercialize a diagnostic and administration solution for a heart disease biomarker discovered by researchers in Cleveland Clinic’s Lerner Research and Heart & Vascular Institutes.
As part of the collaboration, Cleveland HeartLab will develop a diagnostic test to measure blood levels of TMAO, or Trimethylamine-N-oxide, a substance produced by gut bacteria and that is linked to heart disease. Meanwhile, Cleveland Clinic researchers will work with Cincinnati-based P&G to develop an over-the-counter product that can assist people manage their TMAO levels.
In 2011, a research team led by Dr. Stanley Hazen, vice chair of translational research at the Lerner Research Institute, discovered that elevated blood levels of TMAO are linked to improved risk of heart attack, stroke, and death. Their studies also showed that TMAO directly contributes to the narrowing of artery walls through atherosclerotic plaque build-up. TMAO gets formed when a dietary nutrient called lecithin, which is most abundant in animal products rich in fat and cholesterol, gets metabolized by the natural bacterial flora in the gastrointestinal tract.
The Procter & Gamble Company, together with its auxiliaries, manufactures and sells branded consumer packaged products worldwide. It operates through five segments: Beauty, Hair and Personal Care; Grooming; Health Care; Fabric Care and Home Care; and Baby, Feminine and Family Care.
Shares of Target Corporation (NYSE:TGT), inclined 3.92% to $76.84, during its last trading session.
Target Corporation, stated second quarter 2015 adjusted earnings per share from ongoing operations (Adjusted EPS) of $1.22, up 20.6 percent from $1.01 in 2014. GAAP EPS from ongoing operations were $1.21, contrast with $0.61 in second quarter 2014. The tables attached to this press release provide a reconciliation of non-GAAP to GAAP measures. All earnings per share figures refer to diluted EPS.
“We’re very happy with our second quarter financial results, as traffic growth, strong sales in our signature categories and continued expense discipline drove better-than-predictable profitability,” said Brian Cornell, chairman and CEO of Target. “While the momentum in our financial results is encouraging, we have much more to accomplish. Looking ahead, we are focused on making further progress against our planned priorities and are committed to improving operations as we move through the important back-to-school, back-to-college and holiday seasons.”
Target Corporation operates as a general merchandise retailer in the United States and Canada. It offers household essentials, counting pharmacy, beauty, personal care, baby care, cleaning, and paper products; music, movies, books, computer software, sporting goods, and toys; electronics, such as video game hardware and software; and apparel for women, men, boys, girls, toddlers, infants, and newborns, in addition to intimate apparel, jewelry, accessories, and shoes.
Finally, Sunrun Inc (NASDAQ:RUN), ended its last trade with 8.89% gain, and closed at $10.78.
Sunrun, declared that it will issue its second quarter 2015 earnings report after the market closes on Thursday, September 10, 2015.
Sunrun Inc. develops, owns, manages, and sells residential solar energy systems. It distributes solar energy products and material used in the design, installation, and maintenance of solar energy systems. The company also develops and sells mounting structures through the installation and distribution operations under the SnapNrack brand.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
